Teleflex Incorporated will host a conference call to discuss its second quarter 2026 financial results and provide an operational update on August 6, 2026. The call is scheduled to begin at 8:00 a.m. Eastern Time. Investors and interested parties can access the live audio webcast through the company’s website at teleflex.com.

To participate via telephone, individuals must pre-register using the provided link to receive dial-in information. The company has also arranged for an audio replay of the conference call, which will be available starting at 11:00 a.m. Eastern Time on August 6, 2026. The replay can be accessed online or by phone.

Conference Call Details

For those accessing the replay by telephone, the company provided specific dial-in numbers for different regions. Participants in the U.S. and Canada can dial 1 800 770 2030, while those in all other locations should dial 1 609 800 9909. The conference ID required for access is 69028.

Teleflex Incorporated operates as a global provider of medical technologies, offering a portfolio of solutions in therapy areas such as anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. The company’s portfolio includes trusted brands such as Arrow, Barrigel, Deknatel, LMA, Pilling, QuikClot, Rüsch, UroLift, and Weck.

Teleflex Incorporated has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the agreement allows Premier members, at their discretion, to access special pricing and terms pre-negotiated by Premier for select Teleflex products. The agreement covers short-term central venous catheters, arterial catheter products, and intraosseous vascular access solutions.

Cris Gomide, Vice President and General Manager, Vascular & Emergency Medicine at Teleflex, stated that the expansion supports healthcare systems focusing on patient safety, standardization, and operational efficiency. The agreement provides Premier members access to Teleflex’s Arrow Brand of vascular access solutions, designed to support clinicians and help healthcare organizations advance evidence-based practices.

The product portfolio includes the Arrowg+ard Blue Plus Catheters, which feature broad-spectrum antimicrobial protection designed to help reduce the risk of catheter-related bloodstream infections. Through the agreement, Premier members will have access to a range of Teleflex products aimed at standardizing vascular access products across care settings and maintaining high standards of patient care.

Key Products Available Under Agreement

The solutions are intended to support workflow efficiency and address costs and risks associated with vascular access complications and infections. Teleflex has advanced vascular access innovation through its Arrow Portfolio for more than 40 years.